Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice
Publication date: Available online 2 March 2021Source: Pharmacological ResearchAuthor(s): Enchen Zhou, Zhuang Li, Hiroyuki Nakashima, Ahlam Choukoud, Sander Kooijman, Jimmy F.P. Berbée, Patrick C.N. Rensen, Yanan Wang
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology